Vanguard Personalized Indexing Management
RLAY icon

Vanguard Personalized Indexing Management’s Relay Therapeutics RLAY Stock Holding History

Vanguard Personalized Indexing Management’s Portfolio RLAY Stock Details RLAY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$653K Buy
34,921
+3,339
+11% +$48.5K 0.01% 1234
2026
Q1 		$314K Buy
31,582
+3,995
+14% +$35.7K ﹤0.01% 1583
2025
Q4 		$233K Sell
27,587
-284
-1% -$2.03K ﹤0.01% 1657
2025
Q3 		$145K Buy
27,871
+2,079
+8% +$7.93K ﹤0.01% 1760
2025
Q2 		$89.2K Buy
25,792
+11,990
+87% +$35.7K ﹤0.01% 1757
2025
Q1 		$36.2K Sell
13,802
-3,723
-21% -$14.6K ﹤0.01% 1706
2024
Q4 		$72.2K Buy
+17,525
New +$95.4K ﹤0.01% 1655

Other funds holding RLAY

SIAU
SB Investment Advisers (UK) London, United Kingdom $7.66B AUM 20.12% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
CC
Casdin Capital New York $2B AUM 147.21% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
PA
Perceptive Advisors New York $6.66B AUM 360.84% 1-Year Est. Return
CC
Commodore Capital New York $1.68B AUM 375.52% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
NI
Nextech Invest Zurich, Switzerland $2.11B AUM 413.84% 1-Year Est. Return

Vanguard Personalized Indexing Management's RLAY Position: Q2 2026 in Review

Vanguard Personalized Indexing Management increased its Relay Therapeutics (RLAY) stake by 11% in Q2 2026, buying an estimated $48.5K and bringing the position to 34,921 shares worth $653K. The position accounts for 0.01% of the portfolio, ranked #1234.

Vanguard Personalized Indexing Management first reported a position in RLAY in Q4 2024 and has held it in 7 quarters since. 258 funds tracked by Wall St. Rank hold RLAY as of Q2 2026.

  • Vanguard Personalized Indexing Management held 34,921 shares of Relay Therapeutics worth $653K as of Q2 2026.
  • Vanguard Personalized Indexing Management bought 3,339 Relay Therapeutics shares in Q2 2026, an estimated $48.5K.
  • Relay Therapeutics made up 0.01% of Vanguard Personalized Indexing Management's portfolio in Q2 2026, its #1234 holding.
  • Vanguard Personalized Indexing Management first reported a position in Relay Therapeutics in Q4 2024 and has held it in 7 quarters since.
  • 258 funds tracked by Wall St. Rank held Relay Therapeutics as of Q2 2026.

Based on Vanguard Personalized Indexing Management's 13F filing for Q2 2026, filed 11 Aug 2026.